Jacobs Levy Equity Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-36,063
| Closed | -$480K | – | 1129 |
|
|
2021
Q4 | $480K | Buy |
36,063
+8,136
| +29% | +$108K | ﹤0.01% | 840 |
|
|
2021
Q3 | $1.22M | Buy |
27,927
+18,147
| +186% | +$791K | 0.01% | 715 |
|
|
2021
Q2 | $409K | Sell |
9,780
-1,744
| -15% | -$72.9K | ﹤0.01% | 900 |
|
|
2021
Q1 | $558K | Sell |
11,524
-93
| -0.8% | -$4.5K | ﹤0.01% | 848 |
|
|
2020
Q4 | $1.14M | Sell |
11,617
-932
| -7% | -$91.5K | 0.01% | 689 |
|
|
2020
Q3 | $866K | Sell |
12,549
-3,067
| -20% | -$212K | 0.01% | 691 |
|
|
2020
Q2 | $1.65M | Buy |
15,616
+3,537
| +29% | +$373K | 0.02% | 563 |
|
|
2020
Q1 | $1.07M | Buy |
12,079
+4,467
| +59% | +$397K | 0.01% | 604 |
|
|
2019
Q4 | $869K | Buy |
7,612
+5,321
| +232% | +$607K | 0.01% | 711 |
|
|
2019
Q3 | $142K | Sell |
2,291
-2,570
| -53% | -$159K | ﹤0.01% | 870 |
|
|
2019
Q2 | $379K | Buy |
4,861
+1,583
| +48% | +$123K | 0.01% | 783 |
|
|
2019
Q1 | $442K | Sell |
3,278
-245
| -7% | -$33K | 0.01% | 791 |
|
|
2018
Q4 | $283K | Sell |
3,523
-1,043
| -23% | -$83.8K | 0.01% | 818 |
|
|
2018
Q3 | $479K | Buy |
4,566
+255
| +6% | +$26.8K | 0.01% | 788 |
|
|
2018
Q2 | $431K | Buy |
4,311
+1,388
| +47% | +$139K | 0.01% | 829 |
|
|
2018
Q1 | $368K | Buy |
2,923
+1,995
| +215% | +$251K | 0.01% | 831 |
|
|
2017
Q4 | $155K | Hold |
928
| – | – | ﹤0.01% | 930 |
|
|
2017
Q3 | $292K | Hold |
928
| – | – | 0.01% | 796 |
|
|
2017
Q2 | $276K | Sell |
928
-238
| -20% | -$70.8K | 0.01% | 783 |
|
|
2017
Q1 | $269K | Buy |
1,166
+63
| +6% | +$14.5K | 0.01% | 741 |
|
|
2016
Q4 | $72K | Buy |
1,103
+275
| +33% | +$18K | ﹤0.01% | 925 |
|
|
2016
Q3 | $54K | Hold |
828
| – | – | ﹤0.01% | 990 |
|
|
2016
Q2 | $61K | Sell |
828
-1,092
| -57% | -$80.4K | ﹤0.01% | 1120 |
|
|
2016
Q1 | $218K | Buy |
+1,920
| New | +$218K | ﹤0.01% | 953 |
|